Biomedical Ethics and Regulation
Biomedical Ethics and Regulation is a research topic within Physiology. Science Explorer counts 25k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the regulation, ethical considerations, and challenges surrounding stem cell therapies and clinics. It covers topics such as patient safety, direct-to-consumer marketing, global governance, translational research, and the ethical implications of unproven therapies. The papers also discuss the need for comprehensive regulatory frameworks to ensure the safe and ethical development of regenerative medicine.
- Stem Cell Regulation
- Clinical Trials
- Regulatory Challenges
- Patient Safety
- Direct-to-Consumer Marketing
- Ethical Issues
- Global Governance
- Translational Research
- Unproven Therapies
- Regenerative Medicine
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 2.5k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +14% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Biomedical Ethics and Regulation research?
By volume, the United States and the United Kingdom publish the most (1.7k and 419 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.7k works
- 2 United Kingdom 419 works
- 3 China 297 works
- 4 India 260 works
- 5 Germany 178 works
- 6 France 161 works
- 7 Canada 153 works
- 8 Italy 140 works
- 9 Japan 138 works
- 10 Australia 132 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Biomedical Ethics and Regulation research?
By volume in 2022–2025, BMJ Group (United Kingdom) publishes the most Biomedical Ethics and Regulation research, followed by University of North Carolina at Chapel Hill and Harvard University.
By volume, 2022–2025
- 1 BMJ Group (United Kingdom)?? 42 works
- 2 University of North Carolina at Chapel HillUnited States 33 works
- 3 Harvard UniversityUnited States 29 works
- 4 University College LondonUnited Kingdom 24 works
- 5 Stanford UniversityUnited States 19 works
- 6 King's College LondonUnited Kingdom 19 works
- 7 University of MichiganUnited States 18 works
- 8 Yale UniversityUnited States 17 works
- 9 University of TorontoCanada 17 works
- 10 Brigham and Women's HospitalUnited States 16 works
Who are the leading researchers in Biomedical Ethics and Regulation?
The most-cited researchers publishing on Biomedical Ethics and Regulation include David Moher, Maarten J. Postma and Róbert Langer.
- 1 David Moher Canada 38k citations
- 2 Maarten J. Postma Netherlands 4.6k citations
- 3 Róbert Langer United States 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Biomedical Ethics and Regulation research done?
The largest centres of Biomedical Ethics and Regulation research in 2022–2025 are London (United Kingdom), New York (United States), Beijing (China) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in London, Silver Spring and San Francisco.
Largest cities, 2022–2025
- 1 London United Kingdom 149 works
- 2 New York United States 92 works
- 3 Beijing China 75 works
- 4 Boston United States 69 works
- 5 Paris France 62 works
- 6 Washington D.C. United States 61 works
- 7 Cambridge United States 54 works
- 8 Tokyo Japan 53 works
- 9 London ?? 42 works
- 10 Houston United States 42 works
Where it is the local speciality
- London42.1 works55×
- Silver SpringUS · 20.1 works21×
- San FranciscoUS · 32.0 works5.3×
- BethesdaUS · 30.0 works5.2×
- DurhamUS · 27.2 works4.8×
Location quotient: how much more of its research is in Biomedical Ethics and Regulation than the world average.
Where is the best place to study Biomedical Ethics and Regulation?
Among universities, judged by research, Harvard University, Erasmus University Rotterdam and University of California, San Francisco score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States | 60.9 | 20.9% | 5.0× | 29 | +12.9% |
| 2 | Erasmus University RotterdamNetherlands | 53.2 | 21.1% | 6.1× | 8 | +79.9% |
| 3 | University of California, San FranciscoUnited States | 43.1 | 17.0% | 4.6× | 14 | +10.9% |
| 4 | Wake Forest UniversityUnited States | 43.0 | 15.4% | 7.7× | 9 | +3.4% |
| 5 | University of CambridgeUnited Kingdom | 42.8 | 21.3% | 2.2× | 11 | +28.0% |
| 6 | Stanford UniversityUnited States | 41.8 | 14.4% | 3.5× | 20 | +18.7% |
| 7 | Yale UniversityUnited States | 41.0 | 14.8% | 3.7× | 17 | +23.2% |
| 8 | Johns Hopkins UniversityUnited States | 40.3 | 19.8% | 2.8× | 14 | -5.2% |
| 9 | University of OxfordUnited Kingdom | 40.0 | 16.3% | 2.2× | 13 | +38.5% |
| 10 | KU LeuvenBelgium | 39.6 | 21.8% | 2.3× | 9 | -18.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Biomedical Ethics and Regulation research growing?
Output in 2018–2022 was 14% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Biomedical Ethics and Regulation.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.